Baguio, Francisco C.
HRN: 01-18-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CEFTAZIDIME 1GM (VIAL)
12/28/2022
01/04/2023
IV
1gram
Q8hrs
CAP MR With Presumptive
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes